These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34481012)

  • 1. Structure determination, thermal stability and dissolution rate of δ-indomethacin.
    Andrusenko I; Hamilton V; Lanza AE; Hall CL; Mugnaioli E; Potticary J; Buanz A; Gaisford S; Piras AM; Zambito Y; Hall SR; Gemmi M
    Int J Pharm; 2021 Oct; 608():121067. PubMed ID: 34481012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indomethacin Polymorph δ Revealed To Be Two Plastically Bendable Crystal Forms by 3D Electron Diffraction: Correcting a 47-Year-Old Misunderstanding.
    Lightowler M; Li S; Ou X; Zou X; Lu M; Xu H
    Angew Chem Int Ed Engl; 2022 Feb; 61(7):e202114985. PubMed ID: 34902212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indomethacin polymorphs: Experimental and conformational analysis.
    Aceves-Hernandez JM; Nicolás-Vázquez I; Aceves FJ; Hinojosa-Torres J; Paz M; Castaño VM
    J Pharm Sci; 2009 Jul; 98(7):2448-63. PubMed ID: 19199282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphic Transformation of Indomethacin during Hot Melt Extrusion Granulation: Process and Dissolution Control.
    Xu T; Nahar K; Dave R; Bates S; Morris K
    Pharm Res; 2018 May; 35(7):140. PubMed ID: 29748722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
    Basavoju S; Boström D; Velaga SP
    Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of Indomethacin in Semicrystalline Dispersions: Formation, Transformation, and Segregation.
    Van Duong T; Lüdeker D; Van Bockstal PJ; De Beer T; Van Humbeeck J; Van den Mooter G
    Mol Pharm; 2018 Mar; 15(3):1037-1051. PubMed ID: 29307188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermal, spectroscopic, and ab initio structural characterization of carprofen polymorphs.
    Bruni G; Gozzo F; Capsoni D; Bini M; Macchi P; Simoncic P; Berbenni V; Milanese C; Girella A; Ferrari S; Marini A
    J Pharm Sci; 2011 Jun; 100(6):2321-32. PubMed ID: 21246561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
    Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T
    Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
    Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
    Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity differences of indomethacin solid forms with ammonia gas.
    Chen X; Morris KR; Griesser UJ; Byrn SR; Stowell JG
    J Am Chem Soc; 2002 Dec; 124(50):15012-9. PubMed ID: 12475345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability.
    Crowley KJ; Zografi G
    J Pharm Sci; 2002 Feb; 91(2):492-507. PubMed ID: 11835208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer templating of supercooled indomethacin for polymorph selection.
    McKellar SC; Urquhart AJ; Lamprou DA; Florence AJ
    ACS Comb Sci; 2012 Mar; 14(3):155-9. PubMed ID: 22332944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-state 13C NMR study of indomethacin polymorphism.
    Masuda K; Tabata S; Kono H; Sakata Y; Hayase T; Yonemochi E; Terada K
    Int J Pharm; 2006 Aug; 318(1-2):146-53. PubMed ID: 16675172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study.
    Bertoni S; Albertini B; Ferraro L; Beggiato S; Dalpiaz A; Passerini N
    Eur J Pharm Biopharm; 2019 Jun; 139():132-141. PubMed ID: 30910731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dapsone Form V: A Late Appearing Thermodynamic Polymorph of a Pharmaceutical.
    Braun DE; Vickers M; Griesser UJ
    Mol Pharm; 2019 Jul; 16(7):3221-3236. PubMed ID: 31075201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vibrational spectroscopic investigation of polymorphs and cocrystals of indomethacin.
    Ali HR; Alhalaweh A; Velaga SP
    Drug Dev Ind Pharm; 2013 May; 39(5):625-34. PubMed ID: 22480325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystallization of amorphous indomethacin during dissolution: effect of processing and annealing.
    Greco K; Bogner R
    Mol Pharm; 2010 Oct; 7(5):1406-18. PubMed ID: 20459092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of pH and method of crystallization on the solid physical form of indomethacin.
    Dubbini A; Censi R; Martena V; Hoti E; Ricciutelli M; Malaj L; Di Martino P
    Int J Pharm; 2014 Oct; 473(1-2):536-44. PubMed ID: 25064728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorph screening of an active material.
    Láng P; Kiss V; Ambrus R; Farkas G; Szabó-Révész P; Aigner Z; Várkonyi E
    J Pharm Biomed Anal; 2013 Oct; 84():177-83. PubMed ID: 23845379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.